Across TCGA pan-cancer cohorts, LINC02469 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated LINC02469 data layer.
The strongest signal is observed in thyroid carcinoma (THCA), where higher LINC02469 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC02469 expression acts as an unfavorable survival marker, although some lineages such as THCA and KIRC show a favorable association.
THCA, LUSC, and COAD are the cancer types where LINC02469 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.